An international trial has investigated the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19. The results show that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for. Nearly 4,000 healthcare workers took part in the BRACE trial across 36 sites from five countries, including the Germans Trias Hospital. Researchers from an IGTP tuberculosis research group were involved in the development of the study, which has been published in the New England Journal of Medicine.
At the IGTP TODAY
A state-of-the-art super-resolution fluorescence confocal microscope, called Abberior Infinity, was installed in the high-level biosafety (NCB3) facility of the Centre for Comparative Medicine and Bioimage (CMCiB). The equipment of this class, unique in the region, is a powerful tool for anyone aiming to perform advanced microscopy studies on fully infectious Level 3 pathogens (HIV, SARS-CoV-2, Monkey Pox, TB etc.) The microscope is available for use by all internal and external users via IGTP Microscopy Platform.
CMCiB participates in the preclinical studies of Rob Surgical's surgical robot, the first one designed and manufactured in Catalonia
The centre reaches a milestone in its track-record by adding the first Good Laboratory Practice study in its portfolio where the tested product at the centre will reach clinical trials in humans in accordance with international Good Clinical Practice.
The new episode of the podcast 'Un bri de ciència' is presented under the title "La diabetis tipus 1: quan la defensa t'ataca" (Type 1 diabetes: when your defences attack you). Researcher Marta Vives Pi explains the problems of autoimmune diseases, with an emphasis on type 1 diabetes.
EATRIS, the European infrastructure for translational medicine, has appointed 7 Expert Centres, to provide high value added services historically offered by EATRIS Coordination and Support. Those expert services that are complementary to the existing laboratory research services offered by EATRIS institutions cover crucial areas such as innovation management, regulatory strategy, translational feasibility, and early health technology assessment. With 7 newly appointed Expert Centres, EATRIS will continue serving Europe's translational research efforts and growing demand for expert services.
The visit of the director of the Instituto de Salud Carlos III (ISCIII) -a public body attached to the Ministry of Science and Innovation, responsible for the promotion, coordination and funding of health research- at the Germans Trias i Pujol Research Institute (IGTP) was an opportunity to gain direct insight into the latest advances and research while addressing strategic issues.
In the first episode, "La tuberculosi: la pandèmia dels pobres" (Tuberculosis: the pandemic of the poor), researcher José Domínguez explains the basics of the disease and the current situation of research. This podcast is a way for the centre to reach a wide audience, thanks to a short and dynamic storytelling format.
Germans Trias discovers a biomarker to predict whether tuberculosis infection will lead to active disease
The discovery, published in the journal Pathogens, paves the way for accelerating the design of efficient vaccines and treatments against the disease.
The Can Ruti Working Group Women in Science (WiS) looks back on 5 years of activity and forward to the future of gender perspective and intersectionality in science
To celebrate the Day of Women and Girls in Science on 11 February the Can Ruti Working Group Women in Science (WiS) today held its 5th symposium focussed on Integrating Intersectionality and Gender Perspective in Research, hosted by the IGTP.
European Commission’s drive to launch a medical device created in the Hospital and the Germans Trias i Pujol Research Institute to improve the diagnosis and prognosis of the acute ischaemic stroke
The care and treatment provided to people who suffer an ischemic stroke can improve thanks to a technology developed in Catalonia. This is the purpose of Time is Brain (TiB), a start-up that arose from a scientific project carried out by the Hospital and the Germans Trias i Pujol Research Institute (IGTP), which has just received an investment by the European Union of almost 6 million euros in order for the hospitals to count on a pioneering device to manage acute ischaemic stroke.